Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody Response to G17DT in Gastric Cancer
NCT02450032Phase 2Completed
- Sponsor
- Cancer Advances, Inc.
- Start
- Feb 2000
- Primary completion
- May 2001
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of G17DT immunogen in gastric cancer (GC), sponsored by Cancer Advances, Inc.. Started Feb 2000; status: completed.
02
Drugs
G17DT immunogen
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02450032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02450032.